Effect of Nonalcoholic Fatty Liver Disease and Metabolic Risk Factors on Waitlist Outcomes in Patients With Hepatocellular Carcinoma

by Kelley Weinfurtner, MD, Jennifer L. Dodge, MPH, Francis Y. K. Yao, MD, Neil Mehta, MD
Published 2020-10-01